We have correlated the onset age of refractory Epilepsy with efficacy of Lamotrigine used as add-on for a population of 389 patients treated for at least 2 years. Age groups were defined as ranging for 0 to 3 years, 4 to 12 years, 13 to 20 years and ultimately 21 years and beyond. The result obtained show similar responder frequency in the first two age groups for the Cryptogenetic and Symptomatic Generalized Epilepsy, and in the first three age groups for the Partial Epilepsy.
|Translated title of the contribution||Lamotrigine triveneto study: Correlation between the drug's efficacy and the onset age of epilepsy for its various syndromes|
|Number of pages||2|
|Journal||Bollettino - Lega Italiana contro l'Epilessia|
|Publication status||Published - Oct 2002|
ASJC Scopus subject areas
- Clinical Neurology